Cargando…
A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ‐009
BACKGROUND: Inhalation of apomorphine could be a faster‐acting and more user‐friendly alternative to subcutaneous injection for treating off periods in Parkinson's disease (PD). OBJECTIVE: The aim of this study was to compare the safety and pharmacokinetics of inhaled apomorphine (AZ‐009) with...
Autores principales: | Thijssen, Eva, den Heijer, Jonas, Puibert, David, Moss, Laurence, Lei, Mingzu, Hasegawa, David, Keum, Kyo, Mochel, Ken, Ezzeldin Sharaf, Mohammed, Alfredson, Tom, Zeng, Wenxiang, van Brummelen, Emilie, Naranda, Tatjana, Groeneveld, Geert Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306836/ https://www.ncbi.nlm.nih.gov/pubmed/35048423 http://dx.doi.org/10.1002/mds.28926 |
Ejemplares similares
-
A Placebo‐Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease
por: Thijssen, Eva, et al.
Publicado: (2022) -
Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance
por: Makai-Bölöni, Soma, et al.
Publicado: (2021) -
A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Na(v)1.8 inhibitor, in healthy adults
por: Hijma, Hemme J., et al.
Publicado: (2021) -
A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine
por: Yu, Hui Jing, et al.
Publicado: (2022) -
Bureau no. 23-R-009
por: Jacob, U
Publicado: (1978)